Viewing Study NCT02436993

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2026-02-22 @ 1:00 PM
Study NCT ID: NCT02436993
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-14
First Post: 2015-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
Sponsor: University of California, Irvine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoadjuvant Treatment View
None Carboplatin View
None Paclitaxel View
None Pertuzumab View
None Trastuzumab View
None Bevacizumab View